Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules.

Boger DL, Henriksen SJ, Cravatt BF.

Curr Pharm Des. 1998 Aug;4(4):303-14. Review.

PMID:
10197045
2.

Characterization of the hypnotic properties of oleamide.

Basile AS, Hanus L, Mendelson WB.

Neuroreport. 1999 Apr 6;10(5):947-51.

PMID:
10321465
3.
4.

The serotonergic system may be involved in the sleep-inducing action of oleamide in rats.

Yang JY, Wu CF, Wang F, Song HR, Pan WJ, Wang YL.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):457-62. Epub 2003 Nov 13.

PMID:
14615880
5.

The sleep inducing factor oleamide is produced by mouse neuroblastoma cells.

Bisogno T, Sepe N, De Petrocellis L, Mechoulam R, Di Marzo V.

Biochem Biophys Res Commun. 1997 Oct 20;239(2):473-9.

PMID:
9344854
6.

Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide.

Boger DL, Patterson JE, Guan X, Cravatt BF, Lerner RA, Gilula NB.

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4810-5.

7.

Oleic acid derived metabolites in mouse neuroblastoma N18TG2 cells.

Merkler DJ, Chew GH, Gee AJ, Merkler KA, Sorondo JP, Johnson ME.

Biochemistry. 2004 Oct 5;43(39):12667-74.

PMID:
15449956
8.
9.

Oleamide-mediated sleep induction does not depend on perturbation of membrane homeoviscosity.

Gobbi M, Mennini T, Valle FD, Cervo L, Salmona M, Diomede L.

FEBS Lett. 1999 Dec 17;463(3):281-4.

10.

Chemical characterization of a family of brain lipids that induce sleep.

Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA.

Science. 1995 Jun 9;268(5216):1506-9.

PMID:
7770779
11.

Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.

Murillo-Rodríguez E, Vázquez E, Millán-Aldaco D, Palomero-Rivero M, Drucker-Colin R.

Eur J Pharmacol. 2007 May 7;562(1-2):82-91. Epub 2007 Feb 8.

PMID:
17336288
12.

Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?

Hiley CR, Hoi PM.

Cardiovasc Drug Rev. 2007 Spring;25(1):46-60. Review.

PMID:
17445087
13.

Fatty acid amide hydrolase: from characterization to therapeutics.

Labar G, Michaux C.

Chem Biodivers. 2007 Aug;4(8):1882-902. Review.

PMID:
17712824
14.

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB.

Nature. 1996 Nov 7;384(6604):83-7.

PMID:
8900284
15.

The hypnotic actions of the fatty acid amide, oleamide.

Mendelson WB, Basile AS.

Neuropsychopharmacology. 2001 Nov;25(5 Suppl):S36-9. Review.

16.

Selective effect of oleamide, an endogenous sleep-inducing lipid amide, on pentylenetetrazole-induced seizures in mice.

Wu CF, Li CL, Song HR, Zhang HF, Yang JY, Wang YL.

J Pharm Pharmacol. 2003 Aug;55(8):1159-62.

PMID:
12956907
17.

Endocannabinoid hydrolases.

Ueda N.

Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:521-34. Review.

PMID:
12432941
18.

Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase.

Huitron-Resendiz S, Sanchez-Alavez M, Wills DN, Cravatt BF, Henriksen SJ.

Sleep. 2004 Aug 1;27(5):857-65.

PMID:
15453543
19.

Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems.

Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS.

J Pharmacol Exp Ther. 2001 Oct;299(1):332-42.

20.

An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase.

Patricelli MP, Patterson JE, Boger DL, Cravatt BF.

Bioorg Med Chem Lett. 1998 Mar 17;8(6):613-8.

PMID:
9871570

Supplemental Content

Support Center